December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Unicycive Therapeutics, Inc. - Common Stock (NQ:UNCY)

5.210 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Unicycive Therapeutics, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
Unicycive Therapeutics Featured on Nasdaq Amplify Issuer Spotlight Series
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
News headline image
Where Unicycive Therapeutics Stands With Analysts ↗
 
Via Benzinga
News headline image
Unicycive Announces Second Quarter 2023 Financial Results and Provides Business Update
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
News headline image
CORRECTION FROM SOURCE: 60 Degrees Pharmaceuticals and Unicycive Therapeutics Interviews to Air on Bloomberg TV on the RedChip Money Report(R)
Via ACCESSWIRE
News headline image
Analyst Expectations for Unicycive Therapeutics's Future ↗
 
Via Benzinga
News headline image
What 7 Analyst Ratings Have To Say About Unicycive Therapeutics ↗
 
Via Benzinga
News headline image
What 7 Analyst Ratings Have To Say About Unicycive Therapeutics ↗
 
Via Benzinga
News headline image
60 Degrees Pharmaceuticals and Unicycive Therapeutics Interviews to Air on Bloomberg TV on the RedChip Money Report(R)
Via ACCESSWIRE
News headline image
Unicycive Therapeutics to Participate in the H.C. Wainwright 2nd Annual Kidney Conference
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
News headline image
Unicycive Therapeutics Announces Publication of Positive Comparison of Oxylanthanum Carbonate to Commercially Available Phosphate Binders in the American Journal of Nephrology
Newly Assigned USAN Name, Oxylanthanum Carbonate, replaces Lanthanum Dioxycarbonate 
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
News headline image
Analyst Expectations for Unicycive Therapeutics's Future ↗
 
Via Benzinga
News headline image
Expert Ratings for Unicycive Therapeutics ↗
 
Via Benzinga
News headline image
Nasdaq Jumps 200 Points; Baudax Bio Shares Spike Higher ↗
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1.5% on Friday. The Dow traded up 0.93% to 34,439.75 while the NASDAQ rose 1.54% to 13,800.92. The S&P 500,... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top... 
Via Benzinga
News headline image
Crude Oil Rises Over 1%; Fed's Preferred Inflation Gauge Slows In May ↗
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 1% on Friday. The Dow traded up 0.62% to 34,333.42 while the NASDAQ rose 1.37% to 13,777.52. The S&P 500,... 
Via Benzinga
News headline image
Why Is Enphase Energy (ENPH) Stock Up Today? ↗
Enphase Energy (ENPH) stock is on the rise Friday as investors react to the company expanding its distribution partnership in Europe. 
Via InvestorPlace
News headline image
XPEV Stock Alert: Xpeng’s SUV Pricing Beats Out Tesla’s Model Y ↗
Xpeng (XPEV) stock is rallying higher on Friday after the electric vehicle (EV) company priced its G6 SUV below Tesla's (TSLA) Model Y. 
Via InvestorPlace
News headline image
Why Is Unicycive Therapeutics (UNCY) Down 24% Today? ↗
Unicycive Therapeutics (UNCY) stock is falling on Friday after the medical company provided investors with an update from regulators. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Are Unicycive Therapeutics Shares Trading Lower Today ↗
Unicycive Therapeutics Inc (NASDAQ: UNCY) provided an update based on recent interactions with the FDA concerning the company's New Drug Application (NDA) for lanthanum dioxycarbonate (LDC),  
Via Benzinga
News headline image
Why Renalytix Are Trading Higher By Over 48%; Here Are 20 Stocks Moving Premarket ↗
Gainers Renalytix Plc (NASDAQ: RNLX) shares surged 48.7% to $3.02 in pre-market trading after the company received FDA De Novo marketing authorization for its KidneyIntelX.dkd prognostic test. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
It's the final day of trading this week and we're starting off with a breakdown of the biggest pre-market stock movers worth watching today! 
Via InvestorPlace
News headline image
Unicycive Therapeutics Provides Regulatory Update on Lanthanum Dioxycarbonate Program
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
News headline image
Unicycive to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ET
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
News headline image
Unicycive Therapeutics, Inc. and Alarum Technologies Ltd. Interviews to Air on Bloomberg TV on the RedChip Money Report®
Via ACCESSWIRE
News headline image
Unicycive Announces First Quarter 2023 Financial Results and Provides Business Update
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
News headline image
Unicycive Announces Acceptance of Multiple Datasets to Be Presented at the European Renal Association Congress
Data highlights the potential safety and reno-protective effect of UNI-494 
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
News headline image
10 Short Squeeze Candidates: Getty Images Tops List, PaxMedica Rejoins Top Five, MicroStrategy Moves Up And More ↗
Potential short squeeze plays gained steam in 2021 and continued through 2023 with new traders looking for the next huge move. High short interest and high cost to borrow are among the common traits... 
Via Benzinga
News headline image
5 Short Squeeze Stocks To Watch: Unicycle Therapeutics, Getty Images And More ↗
Potential short squeeze plays gained steam in 2021 and continued through 2022 with new traders looking for the next huge move. High short interest and high cost to borrow are among the common traits... 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.